Aurobindo Pharma has announced an Rs 800 crore share buyback via the tender route, offering Rs 1,475 per share. The buyback opens April 23 and closes April 29, with a higher entitlement for retail investors. The move signals a capital deployment strategy and management confidence despite its modest impact on equity.